This company listing is no longer active
Laboratorio Reig Jofre Dividend
Dividend criteriumcontroles 2/6
Belangrijke informatie
33.6%
Dividendrendement
1,442%
Uitbetalingsratio
| Gemiddelde opbrengst industrie | 2.3% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | n/a |
| Winst per aandeel | €0.066 |
| Dividendrendementsvoorspelling | 2.8% |
Recente dividendupdates
Geen updates
Recent updates
Geen updates
Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Too early to tell whether RJF.D's dividend payments have been stable as they only just started paying a dividend.
Groeiend dividend: Too early to tell if RJF.D's dividend payments are increasing as they only just started paying a dividend.
Dividendrendement versus markt
| Laboratorio Reig Jofre Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (RJF.D) | 33.6% |
| Markt onderkant 25% (ES) | 2.4% |
| Markt Top 25% (ES) | 5.4% |
| Gemiddelde industrie (Pharmaceuticals) | 2.3% |
| Analist prognose (RJF.D) (tot 3 jaar) | 2.8% |
Opmerkelijk dividend: RJF.D's dividend (33.65%) is higher than the bottom 25% of dividend payers in the Spanish market (2.28%).
Hoog dividend: RJF.D's dividend (33.65%) is in the top 25% of dividend payers in the Spanish market (6.05%)
Winstuitkering aan aandeelhouders
Verdiendekking: With its high payout ratio (1442.5%), RJF.D's dividend payments are not well covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: RJF.D is paying a dividend but the company has no free cash flows.